Search Results
Results found for "Design Pharmaceuticals"
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
of D2R signaling and explores the potential usefulness of beta-arrestins for the development of new pharmaceutical
- Generic tools won’t solve tomorrow’s drug discovery challenges. That’s why Celtarys designs custom fluorescent probes for every target, built for real pharmacology, not just convenience. With Dr. GPCR and Celtarys joining forces, expect more visibility, more precision, and more scientific impact. 🚀 Get to know our media partner: https://www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem #GPCRdrugDiscovery #GPCRecosystem #CustomLigands | Dr. GPCR Ecosystem
That’s why Celtarys designs custom fluorescent probes for every target, built for real pharmacology, That’s why Celtarys designs custom fluorescent probes for every target, built for real pharmacology,
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
At Monash Institute of Pharmaceutical Sciences, a quiet experiment challenged the traditional PI-silo It shaped how we design experiments, make decisions, and lead teams. In this week’s Dr. Quantifying irreversible activity (K_inact / K_I) — turning persistent binding into measurable design Binding kinetics are a design variable, as critical as potency or clearance. Start designing them to happen.
- Ever wondered how we perceive bitterness? 👅🔬 Researchers have unveiled the cryo-EM structure of TAS2R14, the most promiscuous bitter taste receptor, bound to the drug flufenamic acid (FFA) and its signaling partner gustducin! 🌟 This discovery reveals an unusual dual binding mode of FFA and offers tools for site-targeted compound design. 🧪✨ Learn more about this exciting breakthrough in bitter taste signaling. | Dr. GPCR Ecosystem
This discovery reveals an unusual dual binding mode of FFA and offers tools for site-targeted compound design This discovery reveals an unusual dual binding mode of FFA and offers tools for site-targeted compound design
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
understand how and where these compounds interact with the receptor, paving the way for structure-based drug design He received his Ph.D. in Pharmaceutics from the University of Minnesota in 2022, studying the pharmacokinetics
- 🔬 Enhance Your GPCR Expertise with Dr.GPCR University! Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management? Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive course library covering cutting-edge GPCR science ✅ Practical insights for real-world drug discovery challenges ✅ Flexible, on-demand learning to fit your schedule 🚀 Elevate your expertise today: Start learning now #GPCR #Pharmacology #DrugDiscovery #Biotech #DrGPCR | Dr. GPCR Ecosystem
Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive Dr.GPCR University offers industry-focused courses designed to help you stay ahead in the field. ✅ Comprehensive
- 10 GPCR pharmacology lessons. Zero fluff. Launching July 1, Terry’s Corner gives you the clarity and confidence to make better decisions—starting with: • The role of pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves, orthosteric vs allosteric function, and real vs apparent affinity • Molecular dynamics and how they guide ligand design • Why Terry built this—and how it sharpens your next move 📅 Learn anytime. New course every week. 📬 Subscribe to The Kenakin Brief → https://www.terrykenakin.com #GPCRscience #drugdiscovery #TerrysCorner #GPCRpharmacology #ligandbinding | Dr. GPCR Ecosystem
vs allosteric function, and real vs apparent affinity • Molecular dynamics and how they guide ligand design allosteric function, and real vs apparent affinity 🟢 Molecular dynamics and how they guide ligand design
- Logo Contest for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Submit your design to represent the Adhesion GPCR Workshop and inspire our global community. GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Register Rules for the logo contest Design The Consortium must be free to use the design. The contest deadline is August 15th, 2024, 11:59 PM CST (designs received after the deadline will not be considered) Designs or inquiries should be sent to this email The prize for the selected design will
- Think βCGRP is just αCGRP’s understudy? Think again. New research shows that βCGRP triggers distinct receptor signaling profiles across the CGRP receptor family, challenging the long-held assumption of redundancy. 🔬 A closer look reveals differences in G protein coupling, second messenger production, and receptor trafficking. 📊 This could reshape how we understand CGRP-related physiology—and how we target it in drug design. 🧠 Pain, inflammation, metabolism: the implications go far beyond signaling bias. 🔗 Read the full paper in Biochemistry: Unique Biased Agonism Profile of βCGRP on CGRP Family Receptors #GPCR #CGRP #DrugDiscovery #Pharmacology #SignalTransduction #Neuropeptides | Dr. GPCR Ecosystem
. 📊 This could reshape how we understand CGRP-related physiology—and how we target it in drug design trafficking. 📊 This could reshape how we understand CGRP-related physiology—and how we target it in drug design
- Started in medicinal chemistry. Got hooked on ligand design. Dr. Maria Majellaro didn’t plan to run a biotech company. A thesis project, a mentor’s advice, and a leap during the pandemic changed everything. Now she’s leading Celtarys, building custom fluorescent probes, and partnering with Dr. GPCR to support assay development worldwide. Meet Celtarys and learn more about its leading work on ligand-linker-fluorophore chemistry 🚀 ✳️ Listen now: https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-168-with-dr.-maria-majellaro-from-celtarys #GPCRcommunity #DrGPCR #FluorescentLigands #GPCRdrugDiscovery #ScientificLeadership #BiotechInnovation | Dr. GPCR Ecosystem
Got hooked on ligand design. Dr. Maria Majellaro didn’t plan to run a biotech company. Got hooked on ligand design. Dr. Maria Majellaro didn’t plan to run a biotech company. uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn’t consciously design
- irreversible drugs post 3 | Dr. GPCR Ecosystem
Home → Flash News → irreversible drugs post 3 Irreversible kinetics = strategic lever in drug design. These lessons bridge molecular pharmacology with real-world design strategy, giving discovery teams the Quantifying irreversible activity (K_inact / K_I) — turning persistent binding into measurable design
- GPCR Courses
Measuring and understanding bias helps design drugs that maximize therapeutic benefits while minimizing recording Strategic Project Management for scientists Gain practical project management skills explicitly designed At Dr.GPCR University, you’ll find: • Courses: Dive deep into curated educational content designed by GPCR University Masterclasses designed for? Some classes may require basic knowledge of GPCRs, but many are designed to accommodate beginners as
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine.
- Visualizing GPCRs in their native environment changes everything | Dr. GPCR Ecosystem
Episode 2 reveals new GPCR imaging strategies and tool design insights. Tissue-level insights reshaping metabolic disease research What’s next: multiplex receptor labeling + AI-designed
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
We help GPCR innovators design systems, strategies, and operating frameworks that drive predictable growth Our work helps biotech startups, research organizations, and CROs design operating systems that enable Core themes: Strategic Planning for Biotech Growth Operational System Design (OS) Cross-functional Team you’re leading a GPCR startup, a CRO, or an academic lab ready to scale, Timeline Strategy helps you design
- Courses (All) - Premium | Dr. GPCR Ecosystem
Measuring and understanding bias helps design drugs that maximize therapeutic benefits while minimizing recording Strategic Project Management for scientists Gain practical project management skills explicitly designed Physiological Tissues as a Therapeutic Variable Lecture 3: The Application of GPCR Ligand Kinetics to Candidate Design Techniques for Effective Lead Optimization of Candidate Molecules Lecture 1: GPCR Project Initiation and Design
- irreversible drugs post 2 | Dr. GPCR Ecosystem
Explore the kinetic principles behind persistent binding and smarter drug design. Binding kinetics are a design variable, as critical as potency or clearance.
- University | Dr. GPCR Ecosystem
Learn from leading GPCR experts — anytime, anywhere Access trusted, on-demand courses designed to help Members-only networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed At Dr.GPCR University, you’ll find: • Courses: Dive deep into curated educational content designed by GPCR University Masterclasses designed for? Some classes may require basic knowledge of GPCRs, but many are designed to accommodate beginners as
- GPCR Retreat Logo Contest | Dr. GPCR Ecosystem
Design our brand's identity today! The winning logo designer will receive well-deserved recognition and a cash prize of $250.
- ep 175 with jens carlsson release picture | Dr. GPCR Ecosystem
Discover how embracing failure turned frustration into a breakthrough career designing GPCR experiments Start designing them to happen.
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
Other academic interests of his include studying pharmaceutical finance & healthcare administration and
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Sabbagh was recruited by Vertex Pharmaceuticals (Canada) where he worked on biomarker discovery for inflammatory
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She has advanced the use of computational methods to meet the challenges of designing therapeutics with molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors and drug design
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
Now at the University of Glasgow, his primary research interests are focused on the rational design of at the University of Glasgow underpinned by a £118M new build that will house over 550 researchers designed
- Dr. GPCR Ecosystem | Connect, Collaborate, and Innovate
Free Today 🔒 Go Premium Strategic Partner(s) Your Path to GPCR Mastery Flexible, career-ready courses designed Members-only networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before Stay ahead of the curve with expert-led programs designed for real-world biotech challenges. → Explore biotech innovators and showcase your expertise Training & Upskilling Specialized, insight-packed courses designed
- terrys corner no fluff pure insight | Dr. GPCR Ecosystem
✨ We've poured our passion for pharmacology into creating this essential resource, designed to meet you
- Trainee Symposium I
primarily directed towards methods that study GPCRs and GPCR signaling, as well as drug discovery and design GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain
- Did you know allosteric modulators can change the GPCR G protein subtype selectivity? Have a look at this study to dive deep into its molecular mechanism. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. | Dr. GPCR Ecosystem
. ➡ https:// www.ecosystem.drgpcr.com/gpcr-binders-drugs-and-more/design-of-allosteric-modulators-that-change-gpcr-g-protein-subtype-selectivity
- encoding and decoding selectivity and promiscuity in the human chemokine GPCR interaction network | Dr. GPCR Ecosystem
The result: a framework for designing ligands with altered receptor preferences. ♦️ Defines “public”








